Related Experiment Video
Updated: Feb 15, 2026

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay
Published on: July 13, 2017
Clinical and laboratory profile of anti-M
Debapriya Basu1, Sabita Basu1, Mahua Reddy1
1Transfusion Medicine, Tata Medical Center, 14 Middle Arterial Road (EW), Rajarhat, New Town, Kolkata, India.
Conclusions:
Anti-M is a frequently detected naturally occurring antibody that has been reported in various clinical settings and also in voluntary donors. We describe here the clinical and laboratory findings of 11 cases with anti-M detected at our center. This report is a retrospective study in which we reviewed our immunohematology laboratory records for cases involving anti-M. Both donor and patient data from a 28-month period (September 2014 to December 2016) were reviewed. During this period, 11 examples of anti-M were detected (8 patients, 1 voluntary whole blood donor, and 1 hematopoietic stem cell donor. Anti-M was also detected in one external quality assessment scheme sample received during this period. In conclusion, anti-M can be detected in various clinical settings. This antibody can be clinically significant; in the laboratory, it can present as a serologic problem such as an ABO group discrepancy or an incompatible crossmatch. After detection, management and course of action is determined by both the antibody characteristics and the clinical setting.
Insights
Anti-M antibodies are naturally occurring and can be found in patients and donors. These antibodies may cause significant clinical issues, including blood transfusion complications and laboratory discrepancies.
Area of Science:
- Immunohematology
- Transfusion Medicine
Background:
- Naturally occurring Anti-M antibodies are frequently detected in various clinical settings and among blood donors.
- Understanding the clinical significance and laboratory behavior of Anti-M is crucial for safe transfusion practices.
Purpose of the Study:
- To describe the clinical and laboratory findings of 11 cases where Anti-M was detected.
- To highlight the potential clinical significance and serologic challenges posed by Anti-M.
Main Methods:
- Retrospective review of immunohematology laboratory records.
- Analysis of donor and patient data over a 28-month period (September 2014 to December 2016).
Main Results:
- Eleven instances of Anti-M detection were identified.
- Cases included patients, a whole blood donor, a hematopoietic stem cell donor, and an external quality assessment sample.
- Anti-M can manifest as ABO group discrepancies or incompatible crossmatches.
Conclusions:
- Anti-M antibodies can be detected across diverse clinical scenarios, including in donors and patients.
- Clinical significance varies, and Anti-M can present laboratory challenges.
- Management strategies depend on antibody characteristics and the specific clinical context.
Related Concept Videos
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Clinical Trials
There are four phases in a clinical trial. A phase one...
Waterproofing and Anti-Bacterial Admixtures in Concrete
Waterproofing admixtures render concrete hydrophobic,...
Serum Laboratory Studies, Stool Test, Breath Test
Clinical Trials: Overview

